Key Updates
Airbus SE has declined 2.05% to $172.04 since the March 11th report, breaking below the critical $175.52 support level and establishing a new multi-month low. The stock continues its downward trajectory with YTD losses now at -13.29%, significantly underperforming both its 12-month performance (+11%) and rival Boeing's 32% gain over the same period. No new fundamental developments have emerged since the February 19th earnings announcement, suggesting the ongoing decline reflects continued market digestion of the conservative 870-aircraft delivery guidance and persistent Pratt & Whitney engine supply constraints.
Current Trend
Airbus SE is in a sustained downtrend, declining 13.29% year-to-date and 10.96% over the past six months. The stock has breached multiple support levels, falling from $179.88 resistance (tested March 10th) through $175.52 support (March 6th low) to the current $172.04 level. The consistent negative momentum across all timeframes—1-day (-2.76%), 5-day (-2.18%), 1-month (-10.22%)—indicates persistent selling pressure without meaningful technical relief. The stock trades well below its 12-month high, with the recent price action establishing a pattern of lower highs and lower lows since the February earnings release triggered a 6-7% single-day decline.
Investment Thesis
The investment thesis for Airbus centers on the company's strong fundamental performance—23% profit increase to €5.2bn annually and Q4 2025 adjusted EBIT of €2.98bn (up 17%)—offset by near-term production constraints from supplier dependencies. The structural demand for commercial aircraft remains robust, evidenced by the planned increase from 793 deliveries in 2025 to 870 in 2026, despite this falling short of analyst expectations above 900 units. The company's financial guidance of €7.5bn adjusted EBIT and €4.5bn free cash flow for 2026, combined with a proposed €3.20 dividend per share, demonstrates solid capital allocation. However, the thesis is challenged by execution risks stemming from Pratt & Whitney's inability to deliver ordered engines, forcing production target reductions from 75 to 70-75 A320s monthly by end-2026. The 17 of 25 analysts maintaining Buy ratings suggests the market views current weakness as a potential entry point, though the 32% underperformance versus Boeing over 12 months raises competitive concerns.
Thesis Status
The investment thesis remains fundamentally intact but faces extended timeline risks. The core premise—strong profitability growth and structural aircraft demand—is validated by the 23% profit increase and delivery volume growth. However, the thesis deterioration is evident in three areas: (1) the production ramp-up timeline has been pushed back, with the 75-aircraft monthly target now delayed beyond 2026; (2) supplier dependency risks have materialized more severely than anticipated, with Pratt & Whitney constraints preventing achievement of market expectations; and (3) competitive positioning has weakened, with Boeing's 32% 12-month gain versus Airbus's 11% suggesting market preference shifts. The analyst community's maintenance of Buy ratings (17 of 25) indicates professional investors view this as a clearing event rather than fundamental deterioration, supporting the thesis that current weakness represents temporary execution challenges rather than structural demand issues. The €100bn FCAS fighter jet programme dispute adds uncertainty to the defense segment, though this remains secondary to commercial aviation operations.
Key Drivers
The primary driver remains Pratt & Whitney's engine supply shortage, which has forced Airbus to reduce A320 production targets to 70-75 aircraft monthly by end-2026 from the previous 75-unit goal. This supply chain constraint directly resulted in the conservative 870-aircraft delivery guidance for 2026, below the 900+ unit analyst consensus, triggering the initial 6-7% stock decline on February 19th. CEO Guillaume Faury's indication that Airbus intends to enforce contractual rights against Pratt & Whitney, while acknowledging no quick resolution is expected, signals prolonged production headwinds. Secondary factors include the €100bn FCAS fighter jet programme dispute with Dassault Aviation, where German Chancellor Friedrich Merz's statement that the planned warplane doesn't meet Germany's needs adds uncertainty to defense segment revenues. The competitive dynamic has shifted, with Boeing's 32% 12-month gain versus Airbus's 11% suggesting market participants favor Boeing's recovery trajectory over Airbus's supply-constrained growth.
Technical Analysis
Airbus SE exhibits deteriorating technical conditions, breaking below the $175.52 support level established on March 6th to reach $172.04, a new near-term low. The stock failed to sustain its March 10th recovery attempt, which briefly reached $179.36 near the $179.88 resistance level, before resuming its downtrend. The consistent negative momentum across multiple timeframes—declining 2.76% in one day, 2.18% over five days, and 10.22% over one month—indicates strong selling pressure without evidence of capitulation or exhaustion. The stock trades in a clear downtrend channel with lower highs ($179.88 on March 10th) and lower lows ($172.04 current). The 13.29% YTD decline has accelerated since the February 19th earnings release, with no technical support levels visible until potentially the $170 psychological level. Volume patterns and momentum indicators would likely show continued bearish divergence, though specific data is not provided. The failure to hold the $175.52 level on multiple tests suggests weak buying interest at current valuations despite analyst community support.
Bull Case
- Strong fundamental profitability growth: Airbus reported a 23% profit increase to €5.2bn for the year, with Q4 2025 adjusted EBIT of €2.98bn (up 17% year-over-year), demonstrating robust operational performance despite supply chain headwinds and validating the company's pricing power and cost management capabilities.
- Analyst community maintains conviction: 17 of 25 analysts maintain Buy ratings, viewing the guidance reset as a potential clearing event and attractive entry point, suggesting professional investors believe current weakness is temporary and presents value at depressed levels.
- Delivery volume growth trajectory: Airbus plans to deliver approximately 870 commercial aircraft in 2026, up from 793 in 2025, representing 9.7% year-over-year growth and demonstrating continued production ramp-up despite engine constraints, with A320 accounting for nearly 80% of deliveries in a high-demand narrow-body segment.
- Solid financial guidance and capital returns: The company projects 2026 adjusted EBIT of around €7.5 billion and free cash flow of approximately €4.5 billion, while proposing a dividend increase to €3.20 per share from €3.00, demonstrating confidence in cash generation and commitment to shareholder returns.
- Contractual leverage against supplier: CEO Guillaume Faury indicated Airbus intends to enforce contractual rights against Pratt & Whitney, providing potential for financial compensation or priority treatment that could mitigate supply chain impact and protect margins, though resolution timeline remains uncertain.
Bear Case
- Production targets reduced due to supplier failures: Airbus has reduced its A320 production target to 70-75 aircraft per month by end-2026, down from a previous goal of 75, citing Pratt & Whitney's failure to deliver ordered engines, directly constraining revenue growth and pushing back the production ramp-up timeline that underpins valuation assumptions.
- Delivery guidance significantly below expectations: The 870-aircraft delivery guidance for 2026 fell below analyst expectations above 900 units, triggering a nearly 7% single-day decline and indicating the company cannot meet market growth expectations, with the A320 engine shortage representing a structural constraint rather than temporary disruption.
- Significant underperformance versus competitor: Airbus shares are up 11% over the past 12 months but trail U.S. rival Boeing's 32% gain, suggesting investors favor Boeing's recovery trajectory and raising concerns about Airbus's competitive positioning, market share dynamics, and relative execution capability in the duopoly market structure.
- No quick resolution to supply chain issues: CEO Guillaume Faury acknowledged no quick resolution is expected to the ongoing supply-chain challenges, indicating production constraints will persist through 2026 and potentially beyond, limiting the company's ability to capitalize on strong aircraft demand and potentially resulting in customer delivery delays or cancellations.
- Defense segment uncertainty from FCAS programme dispute: The €100bn Future Combat Air System fighter jet programme faces potential split amid disputes between Airbus and Dassault Aviation, with German Chancellor Friedrich Merz indicating the planned warplane doesn't meet Germany's needs, threatening a major long-term revenue stream and European defense cooperation framework.